A phase I trial of oblimersen sodium in combination with cisplatin and 5-fluorouracil in patients with advanced esophageal, gastroesophageal junction, and gastric carcinoma

Rachel Raab, Joseph A. Sparano, Allyson J. Ocean, Paul Christos, Mark Ramirez, Vincent Vinciguerra, Andreas Kaubisch

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I trial of oblimersen sodium in combination with cisplatin and 5-fluorouracil in patients with advanced esophageal, gastroesophageal junction, and gastric carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences